Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme.
Izumoto S, Tsuboi A, Oka Y, Suzuki T, Hashiba T, Kagawa N, Hashimoto N, Maruno M, Elisseeva OA, Shirakata T, Kawakami M, Oji Y, Nishida S, Ohno S, Kawase I, Hatazawa J, Nakatsuka S, Aozasa K, Morita S, Sakamoto J, Sugiyama H, Yoshimine T.
Izumoto S, et al. Among authors: hashiba t.
J Neurosurg. 2008 May;108(5):963-71. doi: 10.3171/JNS/2008/108/5/0963.
J Neurosurg. 2008.
PMID: 18447714
Clinical Trial.